Australia Diagnostic Imaging Market

Australia Diagnostic Imaging Market Overview:

The Australia diagnostic imaging market size reached USD 977.20 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,717.28 Million by 2033, exhibiting a growth rate (CAGR) of 5.80% during 2025-2033. The market is expanding steadily, driven by advancements in medical imaging technologies for accuracy, efficiency, and safety of diagnostic procedures, increased demand for early disease detection, and growing prevalence of chronic conditions. Government initiatives supporting digital health and improved diagnostic access further contribute to the Australia diagnostic imaging market share.

Australia Diagnostic Imaging Market Trends:

Advancements in Imaging Technology

Rapid technological innovation in diagnostic imaging is a key driver of market growth in Australia. The integration of AI, 3D imaging, PET-CT, MRI, and low-dose radiation systems has improved the accuracy, efficiency, and safety of diagnostic procedures. These advancements enable earlier and more precise detection of conditions such as cancer, cardiovascular disease, and neurological disorders. Australia's robust R&D ecosystem and openness to adopting cutting-edge solutions further support this trend. The incorporation of digital tools, such as teleradiology and cloud-based imaging platforms, also enhances data sharing and remote diagnostics. As both public and private providers invest in next-generation equipment, demand continues to rise across both urban and regional healthcare settings. For instance, in February 2025, the US Advanced Research Projects Agency for Health (ARPA-H) awarded an up to US$16.4m (A$25m) development contract to Micro-X, an Australian X-ray technology business, to create the first full-body mobile CT in history. The Platform Accelerating Rural Access to Distributed and Integrated Medical Care (PARADIGM) initiative of the US Government agency awarded the contract to build a portable, lightweight whole body CT scan.

Rising Incidence of Chronic and Age-Related Diseases

The Australia diagnostic imaging market growth is also driven by the increasing burden of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, combined with an aging population, which is significantly boosting demand for diagnostic imaging in Australia. Elderly patients typically require more frequent monitoring and imaging to manage degenerative diseases and comorbidities. Diagnostic imaging plays a crucial role in early detection, staging, and treatment planning, particularly in oncology and cardiovascular care. As life expectancy increases and lifestyle-related conditions become more prevalent, health services are under pressure to provide accurate, timely diagnoses. Imaging services are essential for preventive care and ongoing disease management, making them indispensable to Australia’s healthcare strategy and a key driver of imaging service expansion. For instance, in March 2025, leading the way in AI-powered intraoperative imaging worldwide, Body Vision Medical reported that the Therapeutic Goods Administration (TGA) in Australia has approved their LungVision advanced imaging system. The company's goal to increase early and accurate lung cancer diagnosis globally has reached a major milestone with this approval.

Australia Diagnostic Imaging Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on modality, application, and end user.

Modality Insights:

• MRI
  • Low and Mid Field MRI Systems
  • High Field MRI Systems
  • Very High and Ultra High Field MRI Systems
• Computed Tomography
  • Low-end Scanners
  • Mid-range Scanners
  • High-end Scanners
• Ultrasound
  • 2D Ultrasound
  • 3D Ultrasound
  • Others
• X-Ray
  • Analog Systems
  • Digital Systems
• Nuclear Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
• Others

The report has provided a detailed breakup and analysis of the market based on the modality. This includes MRI (Low and Mid Field MRI Systems, High Field MRI Systems, and Very High and Ultra High Field MRI Systems), Computed Tomography (Low-end Scanners, Mid-range Scanners, and High-end Scanners), Ultrasound (2D Ultrasound, 3D Ultrasound, and Others), X-Ray (Analog Systems and Digital Systems), Nuclear Imaging (Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT)), and others.

Application Insights:

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others.

End User Insights:

• Hospitals
• Diagnostic Centers
• Others

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, diagnostic centers, and others.

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Diagnostic Imaging Market News:

• In February 2025, Coreline Soft announced its new FDA approval and launch in Australia. After allying with a significant medical device supplier, the South Korean medical imaging AI startup Coreline Soft has arrived in Australia.

Australia Diagnostic Imaging Market Report Coverage:

Key Questions Answered in This Report:

• How has the Australia diagnostic imaging market performed so far and how will it perform in the coming years?
• What is the breakup of the Australia diagnostic imaging market on the basis of modality?
• What is the breakup of the Australia diagnostic imaging market on the basis of application?
• What is the breakup of the Australia diagnostic imaging market on the basis of end user?
• What is the breakup of the Australia diagnostic imaging market on the basis of region?
• What are the various stages in the value chain of the Australia diagnostic imaging market? 
• What are the key driving factors and challenges in the Australia diagnostic imaging market?
• What is the structure of the Australia diagnostic imaging market and who are the key players?
• What is the degree of competition in the Australia diagnostic imaging market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia diagnostic imaging market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia diagnostic imaging market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia diagnostic imaging industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.